Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Sanofi, Sanofi",Alirocumab,hypercholesterolaemia in people with diabetes and acute coronary syndrome (ACS),Alirocumab,,Community and Hospital,Cardiovascular System
